OOIR: Observatory of International Research

Papers

(The H4-Index of European Journal of Clinical Investigation is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
	121
Elevated factor XIa as a modulator of plasma fibrin clot properties in coronary artery disease	84
Adipocyte maturation impacts daunorubicin disposition and metabolism	78
Clinical implications of vascular dysfunction in acute and convalescent COVID‐19: A systematic review	52
Combination therapy with an SGLT‐2 inhibitor and finerenone in DKD: Are we there yet?	47
Role of PERK‐mediated pathway in the effect of mild hypothermia after cerebral ischaemia/reperfusion	46
Human blood metabolites and risk of severe COVID‐19: A Mendelian randomization study	46
Hydrogen sulphide: Diabetic cardiomyopathy as the paradigm of its pleiotropic function	45
Does hospitalisation improve oral anticoagulant optimisation in patients with atrial fibrillation?	44
Effects of pharmacological inhibition of hyaluronic acid synthesis on experimental endometriosis	42
Issue Information	38
rFVIII‐Fc in severe haemophilia A: The incentive switch in case of high risk of joint bleedings	37
Seasonal vitamin D levels and lupus low disease activity state in systemic lupus erythematosus	37
Impact of sirolimus on long‐term adverse cardiovascular outcomes in kidney transplant recipients: A nationwide cohort study	35
Angiotensin‐converting enzyme 2 and transmembrane protease serine 2 in female and male patients with end‐stage kidney disease	35
Issue Information	33
Correction to ‘Association Between Exposure to Air Pollution and Blood Lipids in the General Population of Spain’	33
The use of the Crohn's disease exclusion diet (CDED) in adults with Crohn's disease: A randomized controlled trial	32
ACKR3 agonism induces heterodimerization with chemokine receptor CXCR4 and attenuates platelet function	31
Glucagon and glucagon‐like peptide‐1 dual agonist therapy: A possible future towards fatty kidney disease	31
Social determinants of health and cardiovascular outcomes in patients with heart failure	30
Progress and challenges in the symbiosis of AI with science and medicine	29
Effects of glucagon‐like PEPTIDE‐1 receptor agonists on incidence of hepatocellular carcinoma and liver decompensation in patients with diabetes: A systematic review and META‐analysis	29
Clinical outcomes and phylogenetic analysis in reflection with three predominant clades of SARS‐CoV‐2 variants	28
Hyperventilation testing in the diagnosis of vasospastic angina: A clinical review and meta‐analysis	27

Blood pressure measurement for prediction of chronic pressure overload and cardiovascular events	27
The hinge‐1 domain of Flna is not necessary for diverse physiological functions in mice	27